Page last updated: 2024-10-26

3,3'-diindolylmethane and Bone Loss, Osteoclastic

3,3'-diindolylmethane has been researched along with Bone Loss, Osteoclastic in 2 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Research Excerpts

ExcerptRelevanceReference
"The effects of DIM on experimental arthritis were examined on a rat model of adjuvant-induced arthritis (AIA), with daily AIA paw swelling observation and histological/radiographic analysis."1.363,3'-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis. ( Chen, J; Dong, L; Gao, F; Xia, S; Zhang, D; Zhang, J, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, TY1
Pang, WJ1
Yang, GS1
Dong, L1
Xia, S1
Gao, F1
Zhang, D1
Chen, J1
Zhang, J1

Other Studies

2 other studies available for 3,3'-diindolylmethane and Bone Loss, Osteoclastic

ArticleYear
3,3'-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice.
    Journal of pharmacological sciences, 2015, Volume: 127, Issue:1

    Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Female; Humans; Indoles; Mice; Osteoclasts;

2015
3,3'-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis.
    Biochemical pharmacology, 2010, Mar-01, Volume: 79, Issue:5

    Topics: Animals; Animals, Newborn; Anticarcinogenic Agents; Arthritis, Experimental; Bone Resorption; Cells,

2010